Exchange: NASDAQ·Updated 07:58 PM EST

BLLN Billiontoone Inc. - Ordinary Shares - Class A

$89.92
$0.28
(0.31%)
Today
Closed $89.92
$0.38
(0.42%)
After Hours
Reported EarningsNov 4
Mkt Cap$4.3B
Vol819,497.00

About BLLN

BillionToOne, Inc. is a next-generation molecular diagnostics company on a mission to create powerful and accurate tests that are accessible to all. Its patented Quantitative Counting Templates (QCT) molecular counting platform is a multiplex technology capable of accurately counting DNA molecules at the single-molecule level. The was founded by Oguzhan Atay, Sukrit Silas, and David Tsao in 2016 and is headquartered in Menlo Park, CA.
79

Extremely Bullish Sentiment

How do you feel about BLLN?

Championinvestor
$BLLN Back to $120 a share, what a beautiful response from the company. One of the best companies in the entire sector. $SPY $QQQ
4
Championinvestor
$BLLN “JPMorgan upgrades BilliontoOne stock symbol (BLLN) with a Buy rating, increasing the price to $135 from $130” $QQQ $SPY $NVDA
2
Championinvestor
$BLLN “JPMorgan upgrades BilliontoOne stock symbol (BLLN) with a Buy rating, increasing the price to $135 from $130” $QQQ $SPY $NVDA
2
Smart_Investment
$BLLN You are a joke fool, you only post bearish comments here for months, and you keep on losing money here, how many times have you lost money here you don’t know yourself, because you keep losing money.
1
investor1best
$BLLN Strong Buy stock, everything in this business is running absolutely amazing and infact they're making very high revenues & profits and increased their guidance as well.
1
Smart_Investment
$BLLN This stock is going back to $120 a share. BillionToOne issued a formal rebuttal on November 18, 2026, calling the report "inaccurate, distorted, unsupported, and highly misleading," asserting full compliance with healthcare billing regulations, and stating it is reviewing legal action. Looks like It’s clear now that the report was bogus and the short seller is actually caught into all this lying nonsense. “Fuzzy Panda Research explicitly disclosed that it holds a short position in BillionToOne (NASDAQ: BLLN) and stands to profit from a drop in the share price.”
1
StocktwitsEarnings
$BLLN Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.32 up 220.00% YoY • Reported revenue of $122.98M up 47.25% YoY • BillionToOne raised full year 2026 revenue guidance to $460M to $470M, representing 51% to 54% growth compared to full year 2025, from previous guidance of $450M to $465M.

Advertisement|Remove ads.